Correlation Between Enliven Therapeutics and Biofrontera
Can any of the company-specific risk be diversified away by investing in both Enliven Therapeutics and Biofrontera at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enliven Therapeutics and Biofrontera into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enliven Therapeutics and Biofrontera, you can compare the effects of market volatilities on Enliven Therapeutics and Biofrontera and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enliven Therapeutics with a short position of Biofrontera. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enliven Therapeutics and Biofrontera.
Diversification Opportunities for Enliven Therapeutics and Biofrontera
-0.61 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Enliven and Biofrontera is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Enliven Therapeutics and Biofrontera in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biofrontera and Enliven Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enliven Therapeutics are associated (or correlated) with Biofrontera. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biofrontera has no effect on the direction of Enliven Therapeutics i.e., Enliven Therapeutics and Biofrontera go up and down completely randomly.
Pair Corralation between Enliven Therapeutics and Biofrontera
Given the investment horizon of 90 days Enliven Therapeutics is expected to generate 0.35 times more return on investment than Biofrontera. However, Enliven Therapeutics is 2.85 times less risky than Biofrontera. It trades about -0.18 of its potential returns per unit of risk. Biofrontera is currently generating about -0.06 per unit of risk. If you would invest 2,763 in Enliven Therapeutics on September 2, 2024 and sell it today you would lose (325.00) from holding Enliven Therapeutics or give up 11.76% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Enliven Therapeutics vs. Biofrontera
Performance |
Timeline |
Enliven Therapeutics |
Biofrontera |
Enliven Therapeutics and Biofrontera Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Enliven Therapeutics and Biofrontera
The main advantage of trading using opposite Enliven Therapeutics and Biofrontera positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enliven Therapeutics position performs unexpectedly, Biofrontera can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biofrontera will offset losses from the drop in Biofrontera's long position.Enliven Therapeutics vs. Crinetics Pharmaceuticals | Enliven Therapeutics vs. Enanta Pharmaceuticals | Enliven Therapeutics vs. Amicus Therapeutics | Enliven Therapeutics vs. Connect Biopharma Holdings |
Biofrontera vs. Tff Pharmaceuticals | Biofrontera vs. Eliem Therapeutics | Biofrontera vs. Inhibrx | Biofrontera vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Stocks Directory Find actively traded stocks across global markets | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |